Pfizer vaccine for children under 5 may be available in US by end-Feb - report

accreditation
0:00
play article
Subscribers can listen to this article
  • Pfizer Inc and BioNTech SE are expected to submit an authorisation request for the vaccination of kids aged six months to 5 years.
  • Vaccine shots for children younger than 5 years old could readily be available by end-February.
  • FDA urged the companies to submit the application so that regulators could begin reviewing the two-shot data.


    Pfizer Inc and Germany's BioNTech SE are expected to submit an emergency use authorisation request as early as Tuesday to the US Food and Drug Administration (FDA) for vaccines for children aged six months to 5 years, the Washington Post reported on Monday.

    Coronavirus vaccines for children younger than 5 could be available as soon as end-February under a plan that would lead to the potential authorisation of a two-shot regimen in the coming weeks, the Post reported, citing people briefed on the situation.

    The report says that the FDA urged the companies to submit the application so that regulators could begin reviewing the two-shot data.

    "The idea is, let's go ahead and start the review of two doses," the report quoted one of the people familiar with the situation as saying. "If the data holds up in the submission, you could start kids on their primary baseline months earlier than if you don't do anything until the third-dose data comes in."

    Pfizer, BioNTech and the FDA did not immediately respond to Reuters requests for comment.

    Pfizer said in January it expected the latest results from a clinical trial for kids under the age of 5 by April, after it amended its study to give a third dose to everybody who's less than five at least eight weeks after their last vaccination.

    The company amended the study because children between the ages of 2 and 4 who were given two 3-microgram doses of the vaccine did not have the same immune response that a larger dose of the vaccine generated in older children.


    Never miss a story. Choose from our range of newsletters to get the news you want delivered straight to your inbox.

    We live in a world where facts and fiction get blurred
    In times of uncertainty you need journalism you can trust. For 14 free days, you can have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today. Thereafter you will be billed R75 per month. You can cancel anytime and if you cancel within 14 days you won't be billed. 
    Subscribe to News24
    Voting Booth
    Are you going to keep wearing a mask following the announcement that it is no longer required under law?
    Please select an option Oops! Something went wrong, please try again later.
    Results
    No ways, I'm done
    41% - 2836 votes
    Yes, I still want to be cautious
    21% - 1460 votes
    Only certain circumstances
    38% - 2581 votes
    Vote
    Rand - Dollar
    15.80
    +1.1%
    Rand - Pound
    19.39
    -0.0%
    Rand - Euro
    16.68
    -0.0%
    Rand - Aus dollar
    10.98
    -0.1%
    Rand - Yen
    0.12
    -0.0%
    Gold
    1,827.37
    0.0%
    Silver
    21.15
    0.0%
    Palladium
    1,880.50
    0.0%
    Platinum
    911.50
    0.0%
    Brent Crude
    113.12
    +2.7%
    Top 40
    59,993
    +1.6%
    All Share
    66,349
    +1.6%
    Resource 10
    64,422
    -0.2%
    Industrial 25
    76,590
    +2.6%
    Financial 15
    15,623
    +1.9%
    All JSE data delayed by at least 15 minutes Iress logo
    Editorial feedback and complaints

    Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

    LEARN MORE